Bioneutra Global Stock Price To Book
| BGACF Stock | USD 0.07 0.00 0.00% |
BioNeutra Global fundamentals help investors to digest information that contributes to BioNeutra Global's financial success or failures. It also enables traders to predict the movement of BioNeutra Pink Sheet. The fundamental analysis module provides a way to measure BioNeutra Global's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioNeutra Global pink sheet.
BioNeutra |
BioNeutra Global Company Price To Book Analysis
BioNeutra Global's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, BioNeutra Global has a Price To Book of 0.0 times. This is 100.0% lower than that of the Consumer Defensive sector and 100.0% lower than that of the Packaged Foods industry. The price to book for all United States stocks is 100.0% higher than that of the company.
BioNeutra Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioNeutra Global's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BioNeutra Global could also be used in its relative valuation, which is a method of valuing BioNeutra Global by comparing valuation metrics of similar companies.BioNeutra Global is currently under evaluation in price to book category among its peers.
BioNeutra Fundamentals
| Return On Equity | -2.55 | |||
| Return On Asset | -0.0573 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.14) % | |||
| Current Valuation | 5 M | |||
| Shares Outstanding | 46.45 M | |||
| Shares Owned By Insiders | 36.85 % | |||
| Price To Sales | 0.25 X | |||
| Revenue | 15.4 M | |||
| Gross Profit | 2.89 M | |||
| EBITDA | (1.12 M) | |||
| Net Income | (2.83 M) | |||
| Cash And Equivalents | 1.93 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 6.34 M | |||
| Current Ratio | 0.69 X | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | 271.05 K | |||
| Earnings Per Share | (0.02) X | |||
| Beta | 0.74 | |||
| Market Capitalization | 863.36 K | |||
| Total Asset | 21.08 M | |||
| Net Asset | 21.08 M |
About BioNeutra Global Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioNeutra Global's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioNeutra Global using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioNeutra Global based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in BioNeutra Pink Sheet
BioNeutra Global financial ratios help investors to determine whether BioNeutra Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioNeutra with respect to the benefits of owning BioNeutra Global security.